Showing results (481-490 of 673) with videos related to

Sort By:
Pageof 68
HIV Clinical Trials|January 18, 2011
The relationship of CCR5 antagonists to CD4+ T-cell gain: a meta-regression of recent clinical trials in treatment-experienced HIV-infected patientsTimothy J Wilkin, Heather R Ribaudo, Allan R Tenorio, et al.
HIV Clinical Trials|December 4, 2010
A pilot study of abacavir/lamivudine and raltegravir in antiretroviral-naïve HIV-1-infected patients: 48-week results of the SHIELD trialBenjamin Young, Thanes Vanig, Edwin Dejesus, et al.
HIV Clinical Trials|December 4, 2010
Comparison of antiviral activity of regimens containing nucleos(t)ide (NUC) Pairs in HIV-Infected Patients Initiating REScue therapy (The NUCREST Study)J A Pérez-Molina, O Serrano, A Milinkovic, et al.
HIV Clinical Trials|April 19, 2011
Reduced emergence of the M184V/I resistance mutation when antiretroviral-naïve subjects use emtricitabine versus lamivudine in regimens composed of two NRTIs plus the NNRTI efavirenzDamian J McColl, Nicolas Margot, Shan-Shan Chen, et al.
HIV Clinical Trials|April 19, 2011
Profile of HIV/AIDS patients in a tertiary hospital in Istanbul, TurkeyHayat Kumbasar Karaosmanoglu, Ozlem Altuntas Aydin, Ozcan Nazlican
HIV Clinical Trials|April 19, 2011
A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA studyJustyna D Kowalska, Amanda Mocroft, Bruno Ledergerber, et al.
HIV Clinical Trials|March 11, 2011
Late initiation of HAART among HIV-infected patients in Spain is frequent and related to a higher rate of virological failure but not to immigrant statusJ A Pérez-Molina, I Suárez-Lozano, A Del Arco, et al.
HIV Clinical Trials|March 11, 2011
Postpartum viral load rebound in HIV-1-infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150Beverly E Sha, Camlin Tierney, Susan E Cohn, et al.
HIV Clinical Trials|March 11, 2011
Mitochondrial abnormalities in patients with HIV-HCV co-infection as compared to patients with HCV mono-infectionJean-Marc Chapplain, Pierre Tattevin, Dominique Guyader, et al.
HIV Clinical Trials|August 22, 2014
Clinical and immunologic predictors of death after an acute opportunistic infection: results from ACTG A5164Philip M Grant, Lauren Komarow, Alejandro Sanchez, et al.
Pageof 68